Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a phase I study
| Image |  |
|---|---|
| Description | scholarly article by Marie Luise Hütter-Krönke et al published February 2019 in Haematologica |
| Author/s |
author: Hartmut Döhner |
| Publication date | February 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |